191 related articles for article (PubMed ID: 14693543)
1. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study.
Lee SO; Kim NJ; Choi SH; Hyong Kim T; Chung JW; Woo JH; Ryu J; Kim YS
Antimicrob Agents Chemother; 2004 Jan; 48(1):224-8. PubMed ID: 14693543
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.
Baran G; Erbay A; Bodur H; Ongürü P; Akinci E; Balaban N; Cevik MA
Int J Infect Dis; 2008 Jan; 12(1):16-21. PubMed ID: 17513154
[TBL] [Abstract][Full Text] [Related]
3. An outbreak of imipenem-resistant Acinetobacter baumannii at Songklanagarind Hospital: the risk factors and patient prognosis.
Jamulitrat S; Thongpiyapoom S; Suwalak N
J Med Assoc Thai; 2007 Oct; 90(10):2181-91. PubMed ID: 18041440
[TBL] [Abstract][Full Text] [Related]
4. Acquisition of imipenem-resistant Acinetobacter baumannii in a pediatric intensive care unit: A case-control study.
Katragkou A; Kotsiou M; Antachopoulos C; Benos A; Sofianou D; Tamiolaki M; Roilides E
Intensive Care Med; 2006 Sep; 32(9):1384-91. PubMed ID: 16788807
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and impact of imipenem resistance in Acinetobacter baumannii.
Lautenbach E; Synnestvedt M; Weiner MG; Bilker WB; Vo L; Schein J; Kim M
Infect Control Hosp Epidemiol; 2009 Dec; 30(12):1186-92. PubMed ID: 19860563
[TBL] [Abstract][Full Text] [Related]
6. The Changes in Epidemiology of Imipenem-Resistant
Kim D; Lee H; Choi JS; Croney CM; Park KS; Park HJ; Cho J; Son S; Kim JY; Choi SH; Huh HJ; Ko KS; Lee NY; Kim YJ
J Korean Med Sci; 2022 Jun; 37(24):e196. PubMed ID: 35726147
[TBL] [Abstract][Full Text] [Related]
7. Emergence in Taiwan of novel imipenem-resistant Acinetobacter baumannii ST455 causing bloodstream infection in critical patients.
Lee HY; Huang CW; Chen CL; Wang YH; Chang CJ; Chiu CH
J Microbiol Immunol Infect; 2015 Dec; 48(6):588-96. PubMed ID: 26055692
[TBL] [Abstract][Full Text] [Related]
8. A gloves-associated outbreak of imipenem-resistant Acinetobacter baumannii in an intensive care unit in Guangdong, China.
Ye D; Shan J; Huang Y; Li J; Li C; Liu X; He W; Li Y; Mao P
BMC Infect Dis; 2015 Apr; 15():179. PubMed ID: 25886493
[TBL] [Abstract][Full Text] [Related]
9. Nosocomial imipenem-resistant Acinetobacter baumannii infections: epidemiology and risk factors.
Dizbay M; Tunccan OG; Sezer BE; Hizel K
Scand J Infect Dis; 2010 Oct; 42(10):741-6. PubMed ID: 20500117
[TBL] [Abstract][Full Text] [Related]
10. Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection.
Jamulitrat S; Arunpan P; Phainuphong P
J Med Assoc Thai; 2009 Mar; 92(3):413-9. PubMed ID: 19301737
[TBL] [Abstract][Full Text] [Related]
11. Mutation of CarO participates in drug resistance in imipenem-resistant Acinetobacter baumannii.
Zhu LJ; Chen XY; Hou PF
J Clin Lab Anal; 2019 Oct; 33(8):e22976. PubMed ID: 31318107
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and outcomes of imipenem-resistant Acinetobacter bloodstream infection in North-Eastern Malaysia.
Deris ZZ; Shafei MN; Harun A
Asian Pac J Trop Biomed; 2011 Aug; 1(4):313-5. PubMed ID: 23569782
[TBL] [Abstract][Full Text] [Related]
13. Investigation and control of an outbreak of imipenem-resistant Acinetobacter baumannii Infection in a Pediatric Intensive Care Unit.
Hong KB; Oh HS; Song JS; Lim JH; Kang DK; Son IS; Park JD; Kim EC; Lee HJ; Choi EH
Pediatr Infect Dis J; 2012 Jul; 31(7):685-90. PubMed ID: 22466324
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for the acquisition of imipenem-resistant Acinetobacter baumannii in a burn unit: An appraisal of the effect of colonization pressure.
Cavalcante Rde S; Canet P; Fortaleza CM
Scand J Infect Dis; 2014 Aug; 46(8):593-8. PubMed ID: 24918115
[TBL] [Abstract][Full Text] [Related]
15. Association between antibiotic usage and subsequent colonization or infection of extensive drug-resistant Acinetobacter baumannii: a matched case-control study in intensive care units.
Tsai HT; Wang JT; Chen CJ; Chang SC
Diagn Microbiol Infect Dis; 2008 Nov; 62(3):298-305. PubMed ID: 18707839
[TBL] [Abstract][Full Text] [Related]
16. An OXA-66/OXA-51-like carbapenemase and possibly an efflux pump are associated with resistance to imipenem in Acinetobacter baumannii.
Hu WS; Yao SM; Fung CP; Hsieh YP; Liu CP; Lin JF
Antimicrob Agents Chemother; 2007 Nov; 51(11):3844-52. PubMed ID: 17724156
[TBL] [Abstract][Full Text] [Related]
17. Adaptations of carbapenem resistant
Sharma S; Das A; Banerjee T; Barman H; Yadav G; Kumar A
J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33739918
[No Abstract] [Full Text] [Related]
18. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan.
Lee HY; Chang RC; Su LH; Liu SY; Wu SR; Chuang CH; Chen CL; Chiu CH
Int J Antimicrob Agents; 2012 Aug; 40(2):163-7. PubMed ID: 22743015
[TBL] [Abstract][Full Text] [Related]
19. The impact of inadequate terminal disinfection on an outbreak of imipenem-resistant Acinetobacter baumannii in an intensive care unit.
Liu WL; Liang HW; Lee MF; Lin HL; Lin YH; Chen CC; Chang PC; Lai CC; Chuang YC; Tang HJ
PLoS One; 2014; 9(9):e107975. PubMed ID: 25255439
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology of an outbreak of imipenem-resistant Acinetobacter baumannii carrying the ISAba1-bla(OXA-51-like) genes in a Korean hospital.
Chaulagain BP; Jang SJ; Ahn GY; Ryu SY; Kim DM; Park G; Kim WY; Shin JH; Kook JK; Kang SH; Moon DS; Park YJ
Jpn J Infect Dis; 2012; 65(2):162-6. PubMed ID: 22446125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
